文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Parkin 与 -Synuclein 在 - 介导的帕金森病中的相互作用。

Interaction between Parkin and -Synuclein in -Mediated Parkinson's Disease.

机构信息

Department of Neurobiology Research, Institute of Molecular Medicine, University of Southern Denmark, 5000 Odense, Denmark.

Department of Neurology, Odense University Hospital, 5000 Odense, Denmark.

出版信息

Cells. 2021 Jan 31;10(2):283. doi: 10.3390/cells10020283.


DOI:10.3390/cells10020283
PMID:33572534
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7911026/
Abstract

Parkin and -synuclein are two key proteins involved in the pathophysiology of Parkinson's disease (PD). Neurotoxic alterations of -synuclein that lead to the formation of toxic oligomers and fibrils contribute to PD through synaptic dysfunction, mitochondrial impairment, defective endoplasmic reticulum and Golgi function, and nuclear dysfunction. In half of the cases, the recessively inherited early-onset PD is caused by loss of function mutations in the gene that encodes the E3-ubiquitin ligase, parkin. Parkin is involved in the clearance of misfolded and aggregated proteins by the ubiquitin-proteasome system and regulates mitophagy and mitochondrial biogenesis. -related PD is generally thought not to be associated with Lewy body formation although it is a neuropathological hallmark of PD. In this review article, we provide an overview of post-mortem neuropathological examinations of patients and present the current knowledge of a functional interaction between parkin and -synuclein in the regulation of protein aggregates including Lewy bodies. Furthermore, we describe prevailing hypotheses about the formation of intracellular micro-aggregates (synuclein inclusions) that might be more likely than Lewy bodies to occur in -related PD. This information may inform future studies aiming to unveil primary signaling processes involved in PD and related neurodegenerative disorders.

摘要

Parkin 和 -synuclein 是两种参与帕金森病 (PD) 病理生理学的关键蛋白。-synuclein 的神经毒性改变导致形成毒性寡聚物和纤维,通过突触功能障碍、线粒体损伤、内质网和高尔基体功能缺陷以及核功能障碍导致 PD。在一半的病例中,隐性遗传的早发性 PD 是由编码 E3-泛素连接酶 parkin 的 基因的功能丧失突变引起的。Parkin 参与通过泛素蛋白酶体系统清除错误折叠和聚集的蛋白质,并调节线粒体自噬和线粒体生物发生。虽然 -related PD 是 PD 的神经病理学标志,但一般认为它与 Lewy 体形成无关。在这篇综述文章中,我们提供了对 患者死后神经病理学检查的概述,并介绍了 parkin 和 -synuclein 在调节包括 Lewy 体在内的蛋白质聚集体中的功能相互作用的最新知识。此外,我们描述了关于细胞内微聚集体(synuclein 包含物)形成的流行假说,这些聚集体比 Lewy 体更有可能发生在 -related PD 中。这些信息可能为旨在揭示 PD 和相关神经退行性疾病中涉及的主要信号转导过程的未来研究提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e81b/7911026/07859fb0cfaf/cells-10-00283-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e81b/7911026/39387ec09492/cells-10-00283-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e81b/7911026/6faf894f6490/cells-10-00283-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e81b/7911026/07859fb0cfaf/cells-10-00283-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e81b/7911026/39387ec09492/cells-10-00283-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e81b/7911026/6faf894f6490/cells-10-00283-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e81b/7911026/07859fb0cfaf/cells-10-00283-g003.jpg

相似文献

[1]
Interaction between Parkin and -Synuclein in -Mediated Parkinson's Disease.

Cells. 2021-1-31

[2]
The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.

Apoptosis. 2010-11

[3]
Inclusion body formation and neurodegeneration are parkin independent in a mouse model of alpha-synucleinopathy.

J Neurosci. 2006-4-5

[4]
[Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].

Rinsho Shinkeigaku. 2004

[5]
Role of Deubiquitinases in Parkinson's Disease-Therapeutic Perspectives.

Cells. 2023-2-17

[6]
Parkin and defective ubiquitination in Parkinson's disease.

J Neural Transm Suppl. 2006

[7]
α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.

Exp Neurol. 2018-9-5

[8]
[Pathogenesis of Parkinson's disease: a common pathway between alpha-synuclein and parkin and the mechanism of Lewy bodies formation].

Rinsho Shinkeigaku. 2005-11

[9]
Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.

Science. 2001-7-13

[10]
Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease.

Proc Natl Acad Sci U S A. 2004-12-14

引用本文的文献

[1]
Formation of seeding-competent α-synuclein aggregates in parkin-deficient iPSC-derived human neurons.

NPJ Parkinsons Dis. 2025-6-21

[2]
Mitochondrial quality control disorder in neurodegenerative disorders: Potential and advantages of traditional Chinese medicines.

J Pharm Anal. 2025-4

[3]
The Role of the Ubiquitin System in Eye Diseases.

Life (Basel). 2025-3-20

[4]
Parkin characteristics and blood biomarkers of Parkinson's disease in WPBLC study.

Front Aging Neurosci. 2025-2-26

[5]
Epigenetic Explorations of Neurological Disorders, the Identification Methods, and Therapeutic Avenues.

Int J Mol Sci. 2024-10-30

[6]
Deficiency of parkin causes neurodegeneration and accumulation of pathological α-synuclein in monkey models.

J Clin Invest. 2024-10-15

[7]
Structural and Functional Characterization of the Most Frequent Pathogenic PRKN Substitution p.R275W.

Cells. 2024-9-13

[8]
Palmatine Ameliorates Motor Deficits and Dopaminergic Neuron Loss by Regulating NLRP3 Inflammasome through Mitophagy in Parkinson's Disease Model Mice.

Mol Neurobiol. 2025-2

[9]
Deep cervical lymph nodes in Parkinson's disease and atypical Parkinson's disease: A potential ultrasound biomarker for differential diagnosis.

J Cent Nerv Syst Dis. 2024-7-29

[10]
Differential distribution of PINK1 and Parkin in the primate brain implies distinct roles.

Neural Regen Res. 2025-4-1

本文引用的文献

[1]
Parkin-linked Parkinson's disease: From clinical insights to pathogenic mechanisms and novel therapeutic approaches.

Neurosci Res. 2020-10

[2]
Parkinson's disease: From bench to bedside.

Rev Neurol (Paris). 2020-9

[3]
Parkinson disease.

Eur J Neurol. 2019-11-27

[4]
Mutation Causes Metabolic Disturbances and Impaired Survival of Human iPSC-Derived Neurons.

Front Cell Neurosci. 2019-7-5

[5]
Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes.

Nat Neurosci. 2019-6-24

[6]
α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies.

Neurosci Lett. 2019-6-3

[7]
The Roles of Post-translational Modifications on α-Synuclein in the Pathogenesis of Parkinson's Diseases.

Front Neurosci. 2019-4-18

[8]
α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis.

Biochim Biophys Acta Proteins Proteom. 2019-3-7

[9]
Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.

Neurology. 2019-2-12

[10]
Advances in Parkinson's Disease: 200 Years Later.

Front Neuroanat. 2018-12-14

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索